Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
Int Immunopharmacol
; 102: 107693, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1253055
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Int Immunopharmacol
Journal subject:
Allergy and Immunology
/
Pharmacology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS